From nucleases to donor templates, and all the delivery approaches in between

You're the visionary, the innovator, working hard to improve the lives of an entire patient population. The right partner can help you move your CRISPR-based therapy from discovery through clinical trials more efficiently.

Simplify the sourcing of all your CRISPR gene editing materials from a single vendor, supporting you throughout the entire journey, from research and discovery to cGMP manufacturing.

Discover how our comprehensive offerings can advance your program:

• Streamlining transition to clinical trials: Multiple CRISPR nucleases stocked at research and cGMP grades, with DMFs
• Providing enzymes to your specifications: Custom nuclease manufacturing, including dead Cas9 (base-editors)
• Ensuring research-grade to cGMP quality: gRNA services through partnership with IDT
• Enabling regulatory compliance: First-in-class RNP^* complexing services
• Supporting efficient delivery: mRNA sequence-to-vial services
• Improving knock-in efficiency: Next-generation Nanoplasmid™ donor templates

*Aldevron provides RNPs only to customers who are duly licensed, including to make and have made RNPs, for their intended use.